Immunological adjuvant And NotHans C. Rümke

List of bibliographic references

Number of relevant bibliographic references: 9.

Ident.	Authors (with country if any)	Title
000455	O. Launay [France] ; P. Y. Boelle [France] ; A. Krivine [France] ; D. Grenet [France] ; V. Boussaud [France] ; N. Remus [France] ; H. Corvol [France] ; F. Chedevergne [France] ; D. Hubert [France] ; I. Sermet-Gaudelus [France]	Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis
000458	Nathalie Dhedin [France] ; Anne Krivine [France] ; Nicole Le Corre [France] ; Alain Mallet [France] ; Bruno Lioure [France] ; Jacques-Olivier Bay [France] ; Marie-Thérèse Rubio [France] ; Philippe Agape [Réunion] ; Anne Thiebaut [France] ; Jérôme Le Goff [France] ; Brigitte Autran [France] ; Patricia Ribaud [France]	Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients
000531	J. Haensler [France]	Introduction aux nouveaux adjuvants vaccinaux et à leur rôle dans la vaccination antigrippale
000722	Odile Launay [France] ; Corinne Desaint [France] ; Christine Durier [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Christine Jacomet [France] ; Gilles Pialoux [France] ; Jade Ghosn [France] ; François Raffi [France] ; David Rey [France] ; Faiza Ajana [France] ; Nathalie Colin De Verdiere [France] ; Jacques Reynes [France] ; Valérie Foubert [France] ; François Roman [Belgique] ; Jeanne-Marie Devaster [Belgique] ; Jean-Frangois Delfraissy [France] ; Jean-Pierre Aboulker [France]	Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial
000729	E. Omon [France] ; C. Damase-Michel [France] ; C. Hurault-Delarue [France] ; I. Lacroix [France] ; J. L. Montastruc [France] ; S. Oustric [France] ; B. Escourrou [France]	Non-adjuvanted 2009 influenza A (H1N1 )v vaccine in pregnant women: The results of a French prospective descriptive study
000737	Ida Rosenkrands [Danemark] ; Carina Vingsbo-Lundberg [Danemark] ; Trine Junker Bundgaard [Danemark] ; Thomas Lindenstr M [Danemark] ; Vincent Enouf [France] ; Sylvie Van Der Werf [France] ; Peter Andersen [Danemark] ; Else Marie Agger [Danemark]	Enhanced humoral and cell-mediated immune responses after immunization with trivalent influenza vaccine adjuvanted with cationic liposomes
000738	Emilie Javelle [France] ; Benjamin Soulier ; Christian Brosset ; Solène Lorcy [France] ; Fabrice Simon [France]	Delayed focal lipoatrophy after AS03-adjuvanted influenza A (H1N1) 2009 vaccine
000843	Catherine Caillet [France] ; Fabienne Piras [France] ; Marie-Clotilde Bernard [France] ; Aymeric De Montfort [France] ; Florence Boudet [France] ; Frederick R. Vogel [France] ; Agnès Hoffenbach [France] ; Catherine Moste [France] ; Inca Kusters [France]	AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice
000975	Gregory A. Poland [États-Unis] ; Suryaprakash Sambhara [États-Unis] ; Karin Levie [Belgique] ; Isabel Leroux-Roels [Belgique] ; Karel Hoppenbrouwers [Belgique] ; Anne-Diane Kervyn [Belgique] ; Corinne Vandermeulen [Belgique] ; Sheron Forgus [Belgique] ; Geert Leroux-Roels [Belgique] ; Sylvie Pichon [France] ; Inca Kusters [France]	An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults. Commentary

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021